Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Rek

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|April 18, 2009
Therapeutically targeting protein-glycan interactionsA Rek, E Krenn, A J Kungl
Biochemical Society Transactions|May 20, 2006
Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugsH Potzinger, E Geretti, B Brandner, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|April 18, 2009
Therapeutically targeting protein-glycan interactionsA Rek, E Krenn, A J Kungl
Biochemical Society Transactions|May 20, 2006
Developing chemokine mutants with improved proteoglycan affinity and knocked-out GPCR activity as anti-inflammatory recombinant drugsH Potzinger, E Geretti, B Brandner, et al.
Pageof 1